Personalized epigenomic signatures that are stable over time and covary with body mass index.
The epigenome consists of non-sequence-based modifications, such as DNA methylation, that are heritable during cell division and that may affect normal phenotypes and predisposition to disease. Here, we have performed an unbiased genome-scale analysis of ~4 million CpG sites in 74 individuals with comprehensive array-based relative methylation (CHARM) analysis. We found 227 regions that showed extreme interindividual variability [variably methylated regions (VMRs)] across the genome, which are enriched for developmental genes based on Gene Ontology analysis. Furthermore, half of these VMRs were stable within individuals over an average of 11 years, and these VMRs defined a personalized epigenomic signature. Four of these VMRs showed covariation with body mass index consistently at two study visits and were located in or near genes previously implicated in regulating body weight or diabetes. This work suggests an epigenetic strategy for identifying patients at risk of common disease.
Feinberg
Andrew P
AP
Center for Epigenetics, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. afeinberg@jhu.edu
Irizarry
Rafael A
RA
Fradin
Delphine
D
Aryee
Martin J
MJ
Murakami
Peter
P
Aspelund
Thor
T
Eiriksdottir
Gudny
G
Harris
Tamara B
TB
Launer
Lenore
L
Gudnason
Vilmundur
V
Fallin
M Daniele
MD
D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation / Q000235:genetics*; D044127:Epigenesis, Genetic / Q000235:genetics*; D057890:Epigenomics; D006801:Humans; D013997:Time Factors